Blocking STAT3 signaling augments MEK/ERK inhibitor efficacy in esophageal squamous cell carcinoma

Abstract Esophageal squamous cell carcinoma (ESCC) is one of the world’s leading causes of death, and its primary clinical therapy relies on surgical resection, chemotherapy, radiotherapy, and chemoradiotherapy. Although the genomic features and clinical significance of ESCC have been identified, th...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Zhen-Yuan Zheng, Man-Yu Chu, Wan Lin, Ya-Qi Zheng, Xiu-E Xu, Yang Chen, Lian-Di Liao, Zhi-Yong Wu, Shao-Hong Wang, En-Min Li, Li-Yan Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Publishing Group 2022-05-01
Colecção:	Cell Death and Disease
Acesso em linha:	https://doi.org/10.1038/s41419-022-04941-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!